217 related articles for article (PubMed ID: 30191766)
41. Acute, long-term or non-vincristine-induced peripheral neuropathy among non-Hodgkin lymphoma survivors: Symptoms, daily activities, functional status, and quality of life.
Su YC; Lai YH; Hsieh ST; Teng CJ; Lee YH
Eur J Oncol Nurs; 2024 Apr; 69():102540. PubMed ID: 38461728
[TBL] [Abstract][Full Text] [Related]
42. Precision medicine to improve the risk and benefit of cancer care: genetic factors in vincristine-related neuropathy.
McLeod HL
JAMA; 2015 Feb; 313(8):803-4. PubMed ID: 25710656
[No Abstract] [Full Text] [Related]
43. Genomic determinants of long-term cardiometabolic complications in childhood acute lymphoblastic leukemia survivors.
England J; Drouin S; Beaulieu P; St-Onge P; Krajinovic M; Laverdière C; Levy E; Marcil V; Sinnett D
BMC Cancer; 2017 Nov; 17(1):751. PubMed ID: 29126409
[TBL] [Abstract][Full Text] [Related]
44. Reversible vincristine-related flaccid paralysis in a child with acute lymphoblastic leukemia.
Fioredda F; Micalizzi C; Lanciotti M; Dufour C; Lamba LD; Fiocchi I
Med Pediatr Oncol; 2002 Aug; 39(2):141-2. PubMed ID: 12116067
[No Abstract] [Full Text] [Related]
45. Rationale for an international consortium to study inherited genetic susceptibility to childhood acute lymphoblastic leukemia.
Sherborne AL; Hemminki K; Kumar R; Bartram CR; Stanulla M; Schrappe M; Petridou E; Semsei AF; Szalai C; Sinnett D; Krajinovic M; Healy J; Lanciotti M; Dufour C; Indaco S; El-Ghouroury EA; Sawangpanich R; Hongeng S; Pakakasama S; Gonzalez-Neira A; Ugarte EL; Leal VP; Espinoza JP; Kamel AM; Ebid GT; Radwan ER; Yalin S; Yalin E; Berkoz M; Simpson J; Roman E; Lightfoot T; Hosking FJ; Vijayakrishnan J; Greaves M; Houlston RS
Haematologica; 2011 Jul; 96(7):1049-54. PubMed ID: 21459794
[TBL] [Abstract][Full Text] [Related]
46. Pharmacogenetics of induction therapy-related toxicities in childhood acute lymphoblastic leukemia patients treated with UKALL 2003 protocol.
Aslam S; Ameer S; Shabana NA; Ahmed M
Sci Rep; 2021 Dec; 11(1):23757. PubMed ID: 34887513
[TBL] [Abstract][Full Text] [Related]
47. Association of CEP72 rs924607 TT Genotype with Vincristine-induced Peripheral Neuropathy Measured by Motor Nerve Conduction Studies.
Kavčič M; Zečkanović A; Jazbec J; Debeljak M
Klin Padiatr; 2020 Nov; 232(6):331-333. PubMed ID: 32877958
[TBL] [Abstract][Full Text] [Related]
48. Genetic predisposition to acute lymphoblastic leukemia: Overview on behalf of the I-BFM ALL Host Genetic Variation Working Group.
Kratz CP; Stanulla M; Cavé H
Eur J Med Genet; 2016 Mar; 59(3):111-5. PubMed ID: 26699264
[TBL] [Abstract][Full Text] [Related]
49. The Pharmacogenomics of Vincristine-Induced Neuropathy: On Pins and Needles.
Berg SL; Parsons DW
JAMA Oncol; 2015 Oct; 1(7):975-6. PubMed ID: 26181361
[No Abstract] [Full Text] [Related]
50. Genetic Polymorphisms Associated with Vincristine Pharmacokinetics and Vincristine-Induced Peripheral Neuropathy in Pediatric Oncology Patients.
van de Velde ME; Uittenboogaard A; Yang W; Bonten E; Cheng C; Pei D; van den Berg MH; van der Sluis IM; van den Bos C; Abbink FCH; van den Heuvel-Eibrink MM; Segers H; Chantrain C; van der Werff Ten Bosch J; Willems L; Evans WE; Kaspers GJL
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884569
[TBL] [Abstract][Full Text] [Related]
51. Identification of TP53 as an acute lymphocytic leukemia susceptibility gene through exome sequencing.
Powell BC; Jiang L; Muzny DM; Treviño LR; Dreyer ZE; Strong LC; Wheeler DA; Gibbs RA; Plon SE
Pediatr Blood Cancer; 2013 Jun; 60(6):E1-3. PubMed ID: 23255406
[TBL] [Abstract][Full Text] [Related]
52. A Metabolomics Approach for Early Prediction of Vincristine-Induced Peripheral Neuropathy.
Verma P; Devaraj J; Skiles JL; Sajdyk T; Ho RH; Hutchinson R; Wells E; Li L; Renbarger J; Cooper B; Ramkrishna D
Sci Rep; 2020 Jun; 10(1):9659. PubMed ID: 32541868
[TBL] [Abstract][Full Text] [Related]
53. Whole-exome sequencing exploration of acquired uniparental disomies in B-cell precursor acute lymphoblastic leukemia.
Lundin-Ström KB; Biloglav A; Lilljebjörn H; Rissler M; Fioretos T; Hansson M; Behrendtz M; Castor A; Olsson L; Johansson B
Leukemia; 2018 Sep; 32(9):2058-2062. PubMed ID: 29967378
[No Abstract] [Full Text] [Related]
54. Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.
Tantawy AA; El-Bostany EA; Adly AA; Abou El Asrar M; El-Ghouroury EA; Abdulghaffar EE
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):28-34. PubMed ID: 19923983
[TBL] [Abstract][Full Text] [Related]
55. The impact of CYP3A5*3 on risk and prognosis in childhood acute lymphoblastic leukemia.
Borst L; Wallerek S; Dalhoff K; Rasmussen KK; Wesenberg F; Wehner PS; Schmiegelow K
Eur J Haematol; 2011 Jun; 86(6):477-83. PubMed ID: 21418106
[TBL] [Abstract][Full Text] [Related]
56. Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia.
Ramchandren S; Leonard M; Mody RJ; Donohue JE; Moyer J; Hutchinson R; Gurney JG
J Peripher Nerv Syst; 2009 Sep; 14(3):184-9. PubMed ID: 19909482
[TBL] [Abstract][Full Text] [Related]
57. Vincristine-induced paralytic ileus during induction therapy of treatment protocols for acute lymphoblastic leukemia in adult patients.
Yasu T; Ohno N; Kawamata T; Kurokawa Y
Int J Clin Pharmacol Ther; 2016 Jun; 54(6):471-3. PubMed ID: 27087157
[TBL] [Abstract][Full Text] [Related]
58. Variants in vincristine pharmacodynamic genes involved in neurotoxicity at induction phase in the therapy of pediatric acute lymphoblastic leukemia.
Martin-Guerrero I; Gutierrez-Camino A; Echebarria-Barona A; Astigarraga I; Garcia de Andoin N; Navajas A; Garcia-Orad A
Pharmacogenomics J; 2019 Dec; 19(6):564-569. PubMed ID: 30723315
[TBL] [Abstract][Full Text] [Related]
59. Characterising vincristine-induced peripheral neuropathy in adults: symptom development and long-term persistent outcomes.
Li T; Trinh T; Bosco A; Kiernan MC; Goldstein D; Park SB
Support Care Cancer; 2024 Apr; 32(5):278. PubMed ID: 38592525
[TBL] [Abstract][Full Text] [Related]
60. IL-7 Receptor Mutations and Steroid Resistance in Pediatric T cell Acute Lymphoblastic Leukemia: A Genome Sequencing Study.
Li Y; Buijs-Gladdines JG; Canté-Barrett K; Stubbs AP; Vroegindeweij EM; Smits WK; van Marion R; Dinjens WN; Horstmann M; Kuiper RP; Buijsman RC; Zaman GJ; van der Spek PJ; Pieters R; Meijerink JP
PLoS Med; 2016 Dec; 13(12):e1002200. PubMed ID: 27997540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
